The world is very close to overcoming the current coronavirus pandemic. The companies such as Pfizer and BioNTech have created, tested, and verified COVID-19 vaccines. US Food and Drug Administration has approved these vaccines. The next step is that the offshore shipping companies in Bahrain find a way to successfully distribute and deliver the vaccine. However, the nature of these vaccines suggests that companies must provide specific storage conditions. There was a tremendous impact of COVID-19’s vaccine on cold chain logistics. The companies must find a way how to adapt to these new rules.
The vaccine formula plays an important role in understanding the situation
These vaccines present a significant breakthrough because they contain messenger RNA (mRNA) that instructs human cells to synthesize the SARS-CoV-2 Spike (S) protein. As we already know, the coronavirus uses this protein to enter host cells and attack our organism. When we get a dose of this vaccine, it enables our body to generate an immune response to the virus and remain protected. The problem is that these enzymes are very fragile and they can break down RNA very fact.
In other words, the vaccine needs to be stored at very low temperatures of around -70 ° C. On the other hand, some new evidence suggests that the vaccine can survive at 2 ° to 8 ° C for five days. This is why cargo services in Bahrain have decided to implement the latest standards for their cold-storage services.
Why there was such an impact of COVID-19’s vaccine on cold chain logistics?
Different vaccines require different storage technologies. These are very strict rules, and you should first check if movers in Bahrain or similar logistics companies have the right tools and vehicles to meet these standards. So, let’s first take a look at transport requirements for each vaccine:
- Pfizer vaccine. The company points out that the vaccine should be transported in temperature-controlled thermal shippers. It is also crucial to utilize dry ice to maintain the recommended storage conditions for up to 15 days. The boxes should also include a tracker to provide minute-by-minute information on the internal temperature.
- Moderna vaccine. This vaccine can be stored at -20°C. This means that it requires an easier and more established method of distribution and storage than deep freezing. Most cold-chain pharmaceutical distribution companies already have the capability to store and ship products at this temperature using a number of cold warehouses.
- AstraZeneca vaccine. This vaccine can be distributed using existing logistics and it can be stored in normal refrigerators. This means that most cold-chain logistics companies meet the required standards for the transportation of this vaccine.
As you can see, the impact of COVID-19’s vaccine on cold chain logistics is huge. If the production of the vaccine reaches desired levels, but the logistics and distribution do not, this will create a problem. It is now the logistics companies’ turn to find a way to ensure the delivery of vaccines to entire populations in a short time.